Literature DB >> 21213307

Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.

Rebecca K Brummitt1, Douglas P Nesta, Liuquan Chang, Andrew M Kroetsch, Christopher J Roberts.   

Abstract

Aggregation mechanisms as a function of pH were assessed for the IgG1 antibody described in Part 1 (Brummitt RK, Nesta DP, Chang L, Chase SF, Laue TM, Roberts CJ. Non-native aggregation of an IGG1 antibody in acidic conditions: 1. Unfolding, colloidal interactions, and high molecular weight aggregate formation. J Pharm Sci. In press). Aggregation kinetics along with static light scattering and size-exclusion chromatography indicated that the aggregate nucleus was a dimer for all conditions tested, and this was semiquantitatively consistent with scaling of the characteristic time scale for nucleation (τ(n)) versus protein concentration at pH 4.5 and pH 5.5. Changing pH significantly altered the mechanism of aggregate growth, as well as the size and solubility of aggregates that were formed. Aggregates at pH 3.5 grew primarily by monomer addition and remained small and soluble. Aggregates at pH 4.5 grew first by chain polymerization, followed by condensation polymerization, leading ultimately to large insoluble particles. At pH 5.5, monomer loss resulted primarily in insoluble aggregate formation, with only low levels of soluble aggregate intermediates detected at early times. The influence of pH on aggregate solubility and the reversibility of aggregate phase separation were confirmed via cloud point titrations. Qualitatively, the global aggregation behavior was consistent with reduction of charge-charge repulsions as a primary factor in promoting larger aggregates and aggregate phase separation.
Copyright © 2011 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2011        PMID: 21213307     DOI: 10.1002/jps.22447

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  22 in total

1.  Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1.

Authors:  Haixia Wu; Kristopher Truncali; Julie Ritchie; Rachel Kroe-Barrett; Sanjaya Singh; Anne S Robinson; Christopher J Roberts
Journal:  MAbs       Date:  2015-08-12       Impact factor: 5.857

2.  Reexamining protein-protein and protein-solvent interactions from Kirkwood-Buff analysis of light scattering in multi-component solutions.

Authors:  Marco A Blanco; Erinc Sahin; Yi Li; Christopher J Roberts
Journal:  J Chem Phys       Date:  2011-06-14       Impact factor: 3.488

3.  Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.

Authors:  Paolo Arosio; Simonetta Rima; Massimo Morbidelli
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

4.  Explaining the non-newtonian character of aggregating monoclonal antibody solutions using small-angle neutron scattering.

Authors:  Maria Monica Castellanos; Jai A Pathak; William Leach; Steven M Bishop; Ralph H Colby
Journal:  Biophys J       Date:  2014-07-15       Impact factor: 4.033

5.  Acid-induced aggregation propensity of nivolumab is dependent on the Fc.

Authors:  Boning Liu; Huaizu Guo; Jin Xu; Ting Qin; Lu Xu; Junjie Zhang; Qingcheng Guo; Dapeng Zhang; Weizhu Qian; Bohua Li; Jianxin Dai; Sheng Hou; Yajun Guo; Hao Wang
Journal:  MAbs       Date:  2016-06-16       Impact factor: 5.857

6.  A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.

Authors:  Geetha Thiagarajan; Andrew Semple; Jose K James; Jason K Cheung; Mohammed Shameem
Journal:  MAbs       Date:  2016-05-21       Impact factor: 5.857

7.  Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions.

Authors:  Olubukayo-Opeyemi Oyetayo; Hans Kiefer
Journal:  Pharm Res       Date:  2016-02-29       Impact factor: 4.200

8.  Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.

Authors:  A Singla; R Bansal; Varsha Joshi; Anurag S Rathore
Journal:  AAPS J       Date:  2016-02-22       Impact factor: 4.009

9.  Assessment of physical stability of an antibody drug conjugate by higher order structure analysis: impact of thiol- maleimide chemistry.

Authors:  Jianxin Guo; Sandeep Kumar; Amarnauth Prashad; Jason Starkey; Satish K Singh
Journal:  Pharm Res       Date:  2014-01-24       Impact factor: 4.200

Review 10.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.